Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Optimizing Microbe Factories

10.07.2013
Max Planck and Fraunhofer scientists team up to develop efficient biosynthetic processes for the production of pharmaceutical and industrial ingredients.

A joint research project of the Max Planck and Fraunhofer Societies has received substantial financial support enabling scientists to open the door for new discoveries with immediate industrial applications.


Model plant Arabidopsis thaliana in a tube.
Marion Rehers / Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)

In the next three years, researchers from the Fraunhofer Institute for Molecular Biology and Applied Ecology, Aachen, and the Max Planck Institute for Chemical Ecology, Jena, will join forces for a common project: the optimization of the MEP pathway. Microbes and plant chloroplasts use this metabolic route to produce a diversity of active compounds including many substances humans have been employing as pharmaceuticals, crop protection compounds and industrial materials for thousands of years.

However, the purification or chemical synthesis of these compounds requires extensive efforts. Therefore the goal of the joint project is to utilize bacteria with an optimized MEP pathway to improve the biosynthetic yield of various natural products.

Close relatives: chloroplasts and prokaryotes

The Fraunhofer / Max Planck cooperation is actually based on a natural event that most likely occurred many millions of years ago: In the course of evolution protozoa absorbed other unicellular organisms, such as ancestors of prokaryotic cyanobacteria. According to this theory, the result of this “endosymbiosis” is the development of plants; the cells of all our plant species contain chloroplasts that emerged from ancestral cyanobacteria and still have substantial similarities to free-living prokaryotes.

A few years ago, plant scientists discovered that chloroplasts contain a metabolic pathway which is also found in prokaryotes such as bacteria, that leads to the production of many so-called terpenoid metabolites: the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway, a finding which confirmed the endosymbiont theory. Intermediates of glycolysis are used in the pathway for the multistep synthesis of molecular monomers that consist of five carbon atoms each. These five carbon units can then be combined in many different ways in order to form chlorophyll, carotenoids, cytokinins, sterols and a multitude of other terpenoids. The production of some plant toxins used as defenses against pests is also based on the MEP biosynthetic pathway.

Vitamins and aromas, pharmaceuticals and plant protection compounds: The production of many valuable natural substances is still difficult and expensive.

The discovery of many biologically-active substances in plants and bacteria has proven beneficial to mankind. However, their isolation, purification and processing from natural sources is not only extremely laborious, but also expensive. Chemical synthesis is also difficult or even impossible because these substances usually have complex carbon skeletons that are hard to make in pure forms. For example, the purification of the elementary substance isoprene from mineral oil − a process which is still commonly used today − is neither environmentally friendly, nor economically sustainable. Stefan Jennewein, a scientist at the Fraunhofer Institute for Molecular Biology and Applied Ecology, as well as Louwrance Wright and Jonathan Gershenzon from the Max Planck Institute for Chemical Ecology therefore decided to study the MEP pathway, a metabolic pathway involved in the biosynthesis of the isoprene units, in more detail. They aim to manipulate this pathway in a way that will facilitate a more efficient production of the pharmaceutically relevant substances by using metabolically modified bacteria. The Max Planck scientists will study the regulation of the MEP pathway in chloroplasts of the model plant Arabidopsis thaliana to learn the principles of metabolic control, whereas Stefan Jennewein’s part is to create bacterial strains of the species Escherichia coli and Clostridium ljungdahlii which will be able to produce the required substances in high yield once their MEP pathways have been optimized.

Optimized MEP pathway: better yield, better quality

Thanks to a 1.6 million EUR funding for both institutes in the next three years, the regulation of the seven consecutive enzymatic steps, the levels of the metabolic intermediates, and the transcription of the corresponding genes will be studied. The scientists will use transgenic plants and bacteria in which selected enzymes will be either silenced or overexpressed in order to study potential key roles of particular biosynthetic steps compared to those in untransformed organisms. The researchers also plan to transfer alternative or additional genes to the two bacterial species Escherichia coli and Clostridium ljungdahlii. Applied in high-volume fermenters, MEP pathway-optimized microorganisms should be able to produce higher quantities of the desired substances.

MEP pathway-optimized bacteria are also interesting for their use in chemical industries, especially in the context of processing so-called syngases. Syngas is a mixture of carbon dioxide, carbon monoxide and hydrogen that often accumulates in power plants and steel mills. MEP pathway-optimized Clostridium bacteria with a more efficient isoprene synthase could metabolize these three gases and form isoprene, which may be used to produce a special rubber. Alternatively, syngas could be an intermediate for the production of biofuels. Such a bacteria-based process would be superior to the conventional Fischer-Tropsch synthesis because unpurified syngas could be applied to the fermenters. The Fischer-Tropsch process, on the other hand, which is based on metal catalysis, requires highly purified syngas, and furthermore is highly energy consuming.

Drugs against malaria and cancer

The elucidation of the crucial regulatory steps of the MEP pathway may eventually contribute to the development and production of pharmaceuticals in human medicine, for example against cancer or malaria. The anti-cancer drug taxol and artemisinin, used for the treatment of malaria, could be produced by bacteria whose MEP pathway has been successfully modified. [JWK/AO]

Further information:

Prof. Dr. Jonathan Gershenzon, MPI for Chemical Ecology, gershenzon@ice.mpg.de, +49 3641 57 1301

Dr. Stefan Jennewein, Fraunhofer Institut für Molekularbiologie und Angewandte Ökologie, stefan.jennewein@ime.fraunhofer.de, +49 241 6085 12120

Contact and picture requests:

Angela Overmeyer M.A., Tel. 03641 - 57 2110, overmeyer@ice.mpg.de
or Download via http://www.ice.mpg.de/ext/735.html

Angela Overmeyer | idw
Further information:
http://www.ice.mpg.de/ext/1036.html?&L=0

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>